Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 189

1.

Efficacy and safety of eslicarbazepine acetate as adjunctive therapy for refractory focal-onset seizures in children: A double-blind, randomized, placebo-controlled, parallel-group, multicenter, phase-III clinical trial.

Kirkham F, Auvin S, Moreira J, Gama H, Falcão AC, Rocha JF, Soares-da-Silva P.

Epilepsy Behav. 2020 Mar 6;105:106962. doi: 10.1016/j.yebeh.2020.106962. [Epub ahead of print]

2.

Radiprodil, a NR2B negative allosteric modulator, from bench to bedside in infantile spasm syndrome.

Auvin S, Dozières-Puyravel B, Avbersek A, Sciberras D, Collier J, Leclercq K, Mares P, Kaminski RM, Muglia P.

Ann Clin Transl Neurol. 2020 Mar;7(3):343-352. doi: 10.1002/acn3.50998. Epub 2020 Feb 27.

3.

Report of the first patient with a homozygous OTUD7A variant responsible for epileptic encephalopathy and related proteasome dysfunction.

Garret P, Ebstein F, Delplancq G, Dozieres-Puyravel B, Boughalem A, Auvin S, Duffourd Y, Klafack S, Zieba BA, Mahmoudi S, Singh KK, Duplomb L, Thauvin-Robinet C, Costa JM, Krüger E, Trost D, Verloes A, Faivre L, Vitobello A.

Clin Genet. 2020 Apr;97(4):567-575. doi: 10.1111/cge.13709. Epub 2020 Feb 11.

PMID:
31997314
4.

Epilepsy with migrating focal seizures: KCNT1 mutation hotspots and phenotype variability.

Barcia G, Chemaly N, Kuchenbuch M, Eisermann M, Gobin-Limballe S, Ciorna V, Macaya A, Lambert L, Dubois F, Doummar D, Billette de Villemeur T, Villeneuve N, Barthez MA, Nava C, Boddaert N, Kaminska A, Bahi-Buisson N, Milh M, Auvin S, Bonnefont JP, Nabbout R.

Neurol Genet. 2019 Oct 25;5(6):e363. doi: 10.1212/NXG.0000000000000363. eCollection 2019 Dec.

5.

Homozygous GRN mutations: new phenotypes and new insights into pathological and molecular mechanisms.

Huin V, Barbier M, Bottani A, Lobrinus JA, Clot F, Lamari F, Chat L, Rucheton B, Fluchère F, Auvin S, Myers P, Gelot A, Camuzat A, Caillaud C, Jornéa L, Forlani S, Saracino D, Duyckaerts C, Brice A, Durr A, Le Ber I.

Brain. 2020 Jan 1;143(1):303-319. doi: 10.1093/brain/awz377.

PMID:
31855245
6.

Felbamate for infantile spasms syndrome resistant to first-line treatments.

Dozières-Puyravel B, Nasser H, Bellavoine V, Ilea A, Delanoe C, Auvin S.

Dev Med Child Neurol. 2019 Dec 18. doi: 10.1111/dmcn.14427. [Epub ahead of print]

PMID:
31850517
8.

Fenfluramine for Treatment-Resistant Seizures in Patients With Dravet Syndrome Receiving Stiripentol-Inclusive Regimens: A Randomized Clinical Trial.

Nabbout R, Mistry A, Zuberi S, Villeneuve N, Gil-Nagel A, Sanchez-Carpintero R, Stephani U, Laux L, Wirrell E, Knupp K, Chiron C, Farfel G, Galer BS, Morrison G, Lock M, Agarwal A, Auvin S; FAiRE, DS Study Group.

JAMA Neurol. 2019 Dec 2. doi: 10.1001/jamaneurol.2019.4113. [Epub ahead of print]

9.

Drug Development for Rare Paediatric Epilepsies: Current State and Future Directions.

Auvin S, Avbersek A, Bast T, Chiron C, Guerrini R, Kaminski RM, Lagae L, Muglia P, Cross JH.

Drugs. 2019 Dec;79(18):1917-1935. doi: 10.1007/s40265-019-01223-9. Review.

PMID:
31734883
10.

History of dietary treatment from Wilder's hypothesis to the first open studies in the 1920s.

Höhn S, Dozières-Puyravel B, Auvin S.

Epilepsy Behav. 2019 Dec;101(Pt A):106588. doi: 10.1016/j.yebeh.2019.106588. Epub 2019 Oct 30. Review.

PMID:
31677579
11.

An Evidence-Based Review On The Use Of Perampanel For The Treatment Of Focal-Onset Seizures In Pediatric Patients.

Dozières-Puyravel B, Auvin S.

Neuropsychiatr Dis Treat. 2019 Sep 24;15:2789-2798. doi: 10.2147/NDT.S178405. eCollection 2019.

12.

KCNT1 epilepsy with migrating focal seizures shows a temporal sequence with poor outcome, high mortality and SUDEP.

Kuchenbuch M, Barcia G, Chemaly N, Carme E, Roubertie A, Gibaud M, Van Bogaert P, de Saint Martin A, Hirsch E, Dubois F, Sarret C, Nguyen The Tich S, Laroche C, des Portes V, Billette de Villemeur T, Barthez MA, Auvin S, Bahi-Buisson N, Desguerre I, Kaminska A, Benquet P, Nabbout R.

Brain. 2019 Oct 1;142(10):2996-3008. doi: 10.1093/brain/awz240.

PMID:
31532509
13.

Paediatric-onset neuronal ceroid lipofuscinosis: first symptoms and presentation at diagnosis.

Dozières-Puyravel B, Nasser H, Elmaleh-Bergès M, Lopez Hernandez E, Gelot A, Ilea A, Delanoë C, Puech JP, Caillaud C, Pichard S, Auvin S.

Dev Med Child Neurol. 2020 Apr;62(4):528-530. doi: 10.1111/dmcn.14346. Epub 2019 Sep 5.

PMID:
31489614
14.

A molecule inducing androgen receptor degradation and selectively targeting prostate cancer cells.

Auvin S, Öztürk H, Abaci YT, Mautino G, Meyer-Losic F, Jollivet F, Bashir T, de Thé H, Sahin U.

Life Sci Alliance. 2019 Aug 20;2(4). pii: e201800213. doi: 10.26508/lsa.201800213. Print 2019 Aug.

15.

Absence of increased blood decanoic acid levels in children with epilepsy treated with classic ketogenic diet.

Enderlin J, Loussouarn A, Benoist JF, Dozières-Puyravel B, Auvin S.

Epileptic Disord. 2019 Aug 1;21(4):366-369. doi: 10.1684/epd.2019.1079.

PMID:
31366451
16.

Optimal clinical management of children receiving ketogenic parenteral nutrition: a clinical practice guide.

van der Louw E, Aldaz V, Harvey J, Roan M, van den Hurk D, Cross JH, Auvin S; Review Group.

Dev Med Child Neurol. 2020 Jan;62(1):48-56. doi: 10.1111/dmcn.14306. Epub 2019 Jul 16.

17.

Usefulness of diagnostic tools in a GLUT1 deficiency syndrome patient with 2 inherited mutations.

Dozières-Puyravel B, Zaman S, Petrou S, François L, Vuillaumier-Barrot S, Mochel F, Gras D, Auvin S.

Brain Dev. 2019 Oct;41(9):808-811. doi: 10.1016/j.braindev.2019.05.008. Epub 2019 Jun 10.

PMID:
31196579
18.

Novel seizure outcomes in patients with Lennox-Gastaut syndrome: Post hoc analysis of seizure-free days in rufinamide Study 303.

Auvin S, Williams B, McMurray R, Kumar D, Perdomo C, Malhotra M.

Epilepsia Open. 2019 Mar 13;4(2):275-280. doi: 10.1002/epi4.12314. eCollection 2019 Jun.

19.

Autistic spectrum disorder and epilepsy: diagnostic challenges.

Loussouarn A, Dozières-Puyravel B, Auvin S.

Expert Rev Neurother. 2019 Jun;19(6):579-585. doi: 10.1080/14737175.2019.1617699. Epub 2019 May 13.

PMID:
31081698
20.

A step-wise approach for establishing a multidisciplinary team for the management of tuberous sclerosis complex: a Delphi consensus report.

Auvin S, Bissler JJ, Cottin V, Fujimoto A, Hofbauer GFL, Jansen AC, Jóźwiak S, Kerecuk L, Kingswood JC, Moavero R, Torra R, Villanueva V.

Orphanet J Rare Dis. 2019 Apr 30;14(1):91. doi: 10.1186/s13023-019-1072-y.

21.

History of dietary treatment: Guelpa & Marie first report of intermittent fasting for epilepsy in 1911.

Höhn S, Dozières-Puyravel B, Auvin S.

Epilepsy Behav. 2019 May;94:277-280. doi: 10.1016/j.yebeh.2019.03.018. Epub 2019 Apr 15.

PMID:
30999258
22.

Structural insights reveal a recognition feature for tailoring hydrocarbon stapled-peptides against the eukaryotic translation initiation factor 4E protein.

Lama D, Liberatore AM, Frosi Y, Nakhle J, Tsomaia N, Bashir T, Lane DP, Brown CJ, Verma CS, Auvin S.

Chem Sci. 2019 Jan 7;10(8):2489-2500. doi: 10.1039/c8sc03759k. eCollection 2019 Feb 28.

23.

Perception of impact of Dravet syndrome on children and caregivers in multiple countries: looking beyond seizures.

Nabbout R, Auvin S, Chiron C, Thiele E, Cross H, Scheffer IE, Schneider AL, Guerrini R, Williamson N; Zogenix and Adelphi Values study group.

Dev Med Child Neurol. 2019 Oct;61(10):1229-1236. doi: 10.1111/dmcn.14186. Epub 2019 Mar 4.

PMID:
30828793
24.

Pharmacological treatment of attention-deficit/hyperactivity disorder in children and adolescents with epilepsy.

Auvin S.

Rev Neurol (Paris). 2019 Mar;175(3):141-143. doi: 10.1016/j.neurol.2018.11.003. Epub 2019 Jan 18. Review.

PMID:
30665686
25.

Development of a rapid functional assay that predicts GLUT1 disease severity.

Zaman SM, Mullen SA, Petrovski S, Maljevic S, Gazina EV, Phillips AM, Jones GD, Hildebrand MS, Damiano J, Auvin S, Lerche H, Weber YG, Berkovic SF, Scheffer IE, Reid CA, Petrou S.

Neurol Genet. 2018 Dec 6;4(6):e297. doi: 10.1212/NXG.0000000000000297. eCollection 2018 Dec.

26.

Recommendations for the design of therapeutic trials for neonatal seizures.

Soul JS, Pressler R, Allen M, Boylan G, Rabe H, Portman R, Hardy P, Zohar S, Romero K, Tseng B, Bhatt-Mehta V, Hahn C, Denne S, Auvin S, Vinks A, Lantos J, Marlow N, Davis JM; International Neonatal Consortium.

Pediatr Res. 2019 Jun;85(7):943-954. doi: 10.1038/s41390-018-0242-2. Epub 2018 Dec 24. Review.

27.

Methodologic recommendations and possible interpretations of video-EEG recordings in immature rodents used as experimental controls: A TASK1-WG2 report of the ILAE/AES Joint Translational Task Force.

Akman O, Raol YH, Auvin S, Cortez MA, Kubova H, de Curtis M, Ikeda A, Dudek FE, Galanopoulou AS.

Epilepsia Open. 2018 Oct 11;3(4):437-459. doi: 10.1002/epi4.12262. eCollection 2018 Dec.

28.

Systematic review of the screening, diagnosis, and management of ADHD in children with epilepsy. Consensus paper of the Task Force on Comorbidities of the ILAE Pediatric Commission.

Auvin S, Wirrell E, Donald KA, Berl M, Hartmann H, Valente KD, Van Bogaert P, Cross JH, Osawa M, Kanemura H, Aihara M, Guerreiro MM, Samia P, Vinayan KP, Smith ML, Carmant L, Kerr M, Hermann B, Dunn D, Wilmshurst JM.

Epilepsia. 2018 Oct;59(10):1867-1880. doi: 10.1111/epi.14549. Epub 2018 Sep 3.

29.

Ketogenic diet therapies in France: State of the use in 2018.

Dozières-Puyravel B, François L, de Lucia S, Goujon E, Danse M, Auvin S.

Epilepsy Behav. 2018 Sep;86:204-206. doi: 10.1016/j.yebeh.2018.05.031. Epub 2018 Jul 8.

PMID:
29997039
30.

Optimal clinical management of children receiving dietary therapies for epilepsy: Updated recommendations of the International Ketogenic Diet Study Group.

Kossoff EH, Zupec-Kania BA, Auvin S, Ballaban-Gil KR, Christina Bergqvist AG, Blackford R, Buchhalter JR, Caraballo RH, Cross JH, Dahlin MG, Donner EJ, Guzel O, Jehle RS, Klepper J, Kang HC, Lambrechts DA, Liu YMC, Nathan JK, Nordli DR Jr, Pfeifer HH, Rho JM, Scheffer IE, Sharma S, Stafstrom CE, Thiele EA, Turner Z, Vaccarezza MM, van der Louw EJTM, Veggiotti P, Wheless JW, Wirrell EC; Charlie Foundation; Matthew's Friends; Practice Committee of the Child Neurology Society.

Epilepsia Open. 2018 May 21;3(2):175-192. doi: 10.1002/epi4.12225. eCollection 2018 Jun.

31.

Electro-behavioral phenotype and cell injury following exposure to paraoxon-ethyl in mice: Effect of the genetic background.

Baccus B, Auvin S, Dorandeu F.

Chem Biol Interact. 2018 Jun 25;290:119-125. doi: 10.1016/j.cbi.2018.05.009. Epub 2018 May 22.

PMID:
29800574
32.

The Problem of Rarity: Estimation of Prevalence in Rare Disease.

Auvin S, Irwin J, Abi-Aad P, Battersby A.

Value Health. 2018 May;21(5):501-507. doi: 10.1016/j.jval.2018.03.002. Epub 2018 Apr 5.

33.

Early identification of epileptic encephalopathy with continuous spikes-and-waves during sleep: A case-control study.

Desprairies C, Dozières-Puyravel B, Ilea A, Bellavoine V, Nasser H, Delanöe C, Auvin S.

Eur J Paediatr Neurol. 2018 Sep;22(5):837-844. doi: 10.1016/j.ejpn.2018.04.009. Epub 2018 Apr 27.

PMID:
29739701
34.

Abnormal white matter: Expanding the GLUT1-D phenotype.

Auvin S.

Eur J Paediatr Neurol. 2018 May;22(3):345. doi: 10.1016/j.ejpn.2018.03.007. No abstract available.

PMID:
29653610
35.

A common language of seizures and epilepsies: International League Against Epilepsy 2017 classifications.

Auvin S.

Dev Med Child Neurol. 2018 Apr;60(4):329. doi: 10.1111/dmcn.13694. No abstract available.

36.

Prediction of responders to ketogenic diet based on syndrome and etiology: identification of a new target population?

Auvin S.

Dev Med Child Neurol. 2018 Jul;60(7):644. doi: 10.1111/dmcn.13755. Epub 2018 Mar 22. No abstract available.

37.

Altered vaccine-induced immunity in children with Dravet syndrome.

Auvin S, Jeljeli M, Desnous B, Soussi-Yanicostas N, Dournaud P, Sterkers G.

Epilepsia. 2018 Apr;59(4):e45-e50. doi: 10.1111/epi.14038. Epub 2018 Mar 7.

38.

Development and content validation of a preliminary core set of patient- and caregiver-relevant outcomes for inclusion in a potential composite endpoint for Dravet Syndrome.

Nabbout R, Auvin S, Chiron C, Irwin J, Mistry A, Bonner N, Williamson N, Bennett B.

Epilepsy Behav. 2018 Jan;78:232-242. doi: 10.1016/j.yebeh.2017.08.029. Epub 2017 Nov 4.

39.

High Rate of Recurrent De Novo Mutations in Developmental and Epileptic Encephalopathies.

Hamdan FF, Myers CT, Cossette P, Lemay P, Spiegelman D, Laporte AD, Nassif C, Diallo O, Monlong J, Cadieux-Dion M, Dobrzeniecka S, Meloche C, Retterer K, Cho MT, Rosenfeld JA, Bi W, Massicotte C, Miguet M, Brunga L, Regan BM, Mo K, Tam C, Schneider A, Hollingsworth G; Deciphering Developmental Disorders Study, FitzPatrick DR, Donaldson A, Canham N, Blair E, Kerr B, Fry AE, Thomas RH, Shelagh J, Hurst JA, Brittain H, Blyth M, Lebel RR, Gerkes EH, Davis-Keppen L, Stein Q, Chung WK, Dorison SJ, Benke PJ, Fassi E, Corsten-Janssen N, Kamsteeg EJ, Mau-Them FT, Bruel AL, Verloes A, Õunap K, Wojcik MH, Albert DVF, Venkateswaran S, Ware T, Jones D, Liu YC, Mohammad SS, Bizargity P, Bacino CA, Leuzzi V, Martinelli S, Dallapiccola B, Tartaglia M, Blumkin L, Wierenga KJ, Purcarin G, O'Byrne JJ, Stockler S, Lehman A, Keren B, Nougues MC, Mignot C, Auvin S, Nava C, Hiatt SM, Bebin M, Shao Y, Scaglia F, Lalani SR, Frye RE, Jarjour IT, Jacques S, Boucher RM, Riou E, Srour M, Carmant L, Lortie A, Major P, Diadori P, Dubeau F, D'Anjou G, Bourque G, Berkovic SF, Sadleir LG, Campeau PM, Kibar Z, Lafrenière RG, Girard SL, Mercimek-Mahmutoglu S, Boelman C, Rouleau GA, Scheffer IE, Mefford HC, Andrade DM, Rossignol E, Minassian BA, Michaud JL.

Am J Hum Genet. 2017 Nov 2;101(5):664-685. doi: 10.1016/j.ajhg.2017.09.008.

40.

Expert Opinion on the Management of Lennox-Gastaut Syndrome: Treatment Algorithms and Practical Considerations.

Cross JH, Auvin S, Falip M, Striano P, Arzimanoglou A.

Front Neurol. 2017 Sep 29;8:505. doi: 10.3389/fneur.2017.00505. eCollection 2017. Review.

41.

Functional ultrasound imaging of brain activity in human newborns.

Demene C, Baranger J, Bernal M, Delanoe C, Auvin S, Biran V, Alison M, Mairesse J, Harribaud E, Pernot M, Tanter M, Baud O.

Sci Transl Med. 2017 Oct 11;9(411). pii: eaah6756. doi: 10.1126/scitranslmed.aah6756.

PMID:
29021168
42.

[Evaluating a child after a febrile seizure: Insights on three important issues].

Auvin S, Antonios M, Benoist G, Dommergues MA, Corrard F, Gajdos V, Gras Leguen C, Launay E, Salaün A, Titomanlio L, Vallée L, Milh M.

Arch Pediatr. 2017 Nov;24(11):1137-1146. doi: 10.1016/j.arcped.2017.08.018. Epub 2017 Sep 29. French.

PMID:
28965695
43.

Real-world data on rufinamide treatment in patients with Lennox-Gastaut syndrome: Results from a European noninterventional registry study.

Nikanorova M, Brandt C, Auvin S, McMurray R.

Epilepsy Behav. 2017 Nov;76:63-70. doi: 10.1016/j.yebeh.2017.08.026. Epub 2017 Sep 15.

PMID:
28927712
44.

[Therapeutic management of neonatal arterial cerebral infarction and neuroprotection perspectives].

Baud O, Auvin S, Saliba E, Biran V.

Arch Pediatr. 2017 Sep;24(9S):9S46-9S50. doi: 10.1016/S0929-693X(17)30331-7. French.

PMID:
28867038
45.

Anti-ictogenic and antiepileptogenic properties of perampanel in mature and immature rats.

Dupuis N, Enderlin J, Thomas J, Desnous B, Dournaud P, Allorge D, Auvin S.

Epilepsia. 2017 Nov;58(11):1985-1992. doi: 10.1111/epi.13894. Epub 2017 Aug 29.

46.

Use of perampanel in children and adolescents with Lennox-Gastaut Syndrome.

Auvin S, Dozieres B, Ilea A, Delanoë C.

Epilepsy Behav. 2017 Sep;74:59-63. doi: 10.1016/j.yebeh.2017.05.036. Epub 2017 Jul 14.

PMID:
28715780
47.

Non-ketogenic combination of nutritional strategies provides robust protection against seizures.

Dallérac G, Moulard J, Benoist JF, Rouach S, Auvin S, Guilbot A, Lenoir L, Rouach N.

Sci Rep. 2017 Jul 14;7(1):5496. doi: 10.1038/s41598-017-05542-3.

48.

Clinical studies and anti-inflammatory mechanisms of treatments.

French JA, Koepp M, Naegelin Y, Vigevano F, Auvin S, Rho JM, Rosenberg E, Devinsky O, Olofsson PS, Dichter MA.

Epilepsia. 2017 Jul;58 Suppl 3:69-82. doi: 10.1111/epi.13779.

49.

Prospective clinical trials to investigate clinical and molecular biomarkers.

Auvin S, Walker L, Gallentine W, Jozwiak S, Tombini M, Sills GJ.

Epilepsia. 2017 Jul;58 Suppl 3:20-26. doi: 10.1111/epi.13782. Review.

50.

Role of seizure in neonatal stroke.

Auvin S, Charriaut-Marlangue C.

Oncotarget. 2017 Jul 25;8(30):48531-48532. doi: 10.18632/oncotarget.18212. No abstract available.

Supplemental Content

Support Center